Mesotheliomas with deciduoid morphology: A morphologic spectrum and a variant not confined to young females

American Journal of Surgical Pathology

Volumn 24, Issue 2, 2000, Pages 285-294

  Shanks, Jonathan H ^a   Harris, Martin ^a   Banerjee, S Sankar ^a   Eyden, Brian P ^a   Joglekar, Vijay M ^b   Nicol, Anne ^c   Hasleton, Philip S ^d   Nicholson, Andrew G ^e  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b FURNESS GENERAL HOSPITAL   (United Kingdom)

^c MID CHESHIRE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d WYTHENSHAWE HOSPITAL   (United Kingdom)

^e ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Deciduoid; GANT; Immunohistochemistry; Mesothelioma; Peritoneal neoplasms; Peritoneum; Pleura

Indexed keywords

ALPHA ACTIN; ASBESTOS; CALRETININ; CARCINOEMBRYONIC ANTIGEN; CD15 ANTIGEN; CHROMOGRANIN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; CYTOKERATIN; MUCIN; PROTEIN S 100; SYNAPTOPHYSIN; THROMBOMODULIN; TUMOR MARKER; VIMENTIN;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; MALE; NERVE TUMOR; NONHUMAN; OCCUPATIONAL CARCINOGENESIS; PERITONEUM MESOTHELIOMA; PLEURA MESOTHELIOMA; PROTEIN EXPRESSION; SEX DIFFERENCE; TUMOR BIOPSY;

AGED; DECIDUA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MESOTHELIOMA; MICROVILLI; MIDDLE AGED; PERITONEAL NEOPLASMS; PLEURAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033952817     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200002000-00015     Document Type: Article

References (32)

1. Attanoos RL, Goddard H, Gibbs AR. Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma. Histopathology 1996; 29:209-15.
2. Bateman AC, Al-Talib RK, Newman T, Williams JH, Herben A. Immunohistohemical phenotype of malignant mesothelioma: predictive value of CA 125 and HBME-1 expression. Histopathology 1997;30:49-65.
3. Chan JKC. Proliferative lesions of follicular dendritic cells: an overview, including a detailed account of follicular dendritic cell sarcoma, a neoplasm with many faces and uncommon etiologic associations. Advances in Anatomic Pathology 1997;4:387-411.
4. Chan JK, Fletcher CD, Nayler SJ, Cooper K. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognised. Cancer 1997; 79:294-313.
5. Clement PB, Scully RE. Idiopathic postmenopausal decidual reaction of the endometrium: a clinicopathologic analysis of four cases. Int J Gynaecol Pathol 1988;7:152-61.
6. Clover J, Oates J, Edwards C. Anti-cytokeratin 5/6: a positive marker for epithelioid mesothelioma. Histopathology 1997;31: 140-3.
7. Doglioni C, Dei Tos AP, Laurino L, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996;20:1037-46.
8. Fletcher CDM. Peripheral neuroectodermal tumours. In: Fletcher CDM, ed. Diagnostic Histopathology of Tumours, vol 2. Edinburgh: Churchill Livingstone, 1995:1221-50.
9. Galateau-Sallé F, Matrat M, Paris C, et al. Diffuse malignant mesothelioma of the pleura with prolonged survival. Arch Anat Cytol Pathol 1998;46:581 [abstract 1197].
10. Heatley MK, Maxwell P, Toner PG. The immunophenotype of human decidua and extra-uterine decidual reactions. Histopathology 1996;29:437-42.
11. Herr JC, Fares NH, Banhawy MA. Decidual cells in the human ovary at term. II: morphometric analysis of cytoplasmic processes and organelles. American Journal of Anatomy 1987;179:277-84.
12. Jones MA, Young RH, Scully RE. Malignant mesothelioma of the tunica vaginalis testis. A clinicopathologic analysis of 11 cases with review of the literature. Am J Surg Pathol 1995;19:815-25.
13. Lane B, Oxberry W, Mazella J, Tseng L. Decidualisation of human endometrial stromal cells in vitro: effects of progestin and relaxin on the ultrastructure and production of decidual secretory proteins. Hum Reprod 1994;9:259-66.
14. Latza U, Neidobitek G, Schwarting R, Nekarda H, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 1990;43:213-9.
15. Leers MPG, Aarts MMJ, Theunissen PHMH. E-cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma. Histopathology 1998;32:209-16.
16. Leong AS-Y, Wick MR, Swanson PE, eds. Immunohistology and Electron Microscopy of Anaplastic and Pleomorphic Tumors. Cambridge, UK: Cambridge University Press, 1997.
17. Mark EJ, Shin DH. Diffuse malignant mesothelioma of the pleura: a clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival. Virchows Arch 1993;422:445-51.
18. Mayall FG, Gibbs AR. The histology and immunohistology of small cell mesothelioma. Histopathology 1992;20:47-51.
19. Mayall FG, Jasani G, Gibbs AR. Immunohistochemical positivity for neuron-specific enolase and Leu-7 in malignant mesotheliomas. J Pathol 1991;165:325-8.
20. Nascimento AG, Keeney GL, Fletcher CDM. Deciduoid peritoneal mesothelioma. An unusual phenotype affecting young females. Am J Surg Pathol 1994;18:439-45.
21. Ordóñez NG. Value of thrombomodulin immunostaining in the diagnosis of mesothelioma. Histopathology 1997;31:25-30.
22. Ordóñez NG. The value of antibodies 44-3A6, SM3, HBME-1 and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma. Am J Surg Pathol 1997;21:1399-408.
23. Ordóñez NG. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. Am J Surg Pathol 1998;22:1203-14.
24. Ordóñez NG. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol 1998;22:1215-21.
25. Ordóñez NG. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma. Mod Pathol 1998;11:929-33.
26. Orosz Z, Nagy P, Szentirmay Z, Zalatnai A, Hauser P. Epithelial mesothelioma with deciduoid features. Virchows Arch 1999;434: 263-6.
27. Riera JR, Astengo-Osuna C, Longmate JA, Battifora H. The immunohistochemical diagnostic panel for epithelial mesothelioma. A re-evaluation following heat-induced epitope retrieval. Am J Surg Pathol 1997;21:1409-19.
28. Shanks JH, Harris M, Banerjee SS, Eyden BP. Gastrointestinal autonomic nerve tumours: a report of nine cases. Histopathology 1996;29:111-21.
29. Sheibani K, Shin SS, Kezirian J, Weiss LM. Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol 1991;15:779-84.
30. Suster S, Moran CA. Deciduosis of the appendix. Am J Gastroenterol 1990;85:841-5.
31. Talerman A, Chilcote RR, Montero JR, Okgaki T. Diffuse malignant peritoneal mesothelioma in a 13-year-old girl. Am J Surg Pathol 1985;9:73-80.
32. Weeks DA, Beckwith JB, Mierau GW, Luckey DW. Rhabdoid tumor of the kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol 1989; 13:439-58.